This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Mirati Therapeutics, Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: The Innovative Contributions of Mehrdad Kheiripour
Introduction
Mehrdad Kheiripour is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 2 patents, Kheiripour's work is recognized for its potential impact on patient care.
Latest Patents
Kheiripour's latest patents include the development of Adagrasib solid pharmaceutical compositions. These compositions are designed for oral dosage and are suitable for treating subjects with cancer. The patents also encompass methods of manufacturing these compositions and methods of treating cancer, showcasing Kheiripour's commitment to advancing medical science.
Career Highlights
Kheiripour is currently associated with Mirati Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His work is pivotal in the ongoing efforts to improve cancer therapies and enhance patient outcomes.
Collaborations
Some of Kheiripour's coworkers include Cletus Nunes and Monika Gavireddi. Their collaborative efforts contribute to the dynamic environment at Mirati Therapeutics, fostering innovation and research.
Conclusion
In summary, Mehrdad Kheiripour is a distinguished inventor whose work in pharmaceutical compositions for cancer treatment is noteworthy. His contributions are vital to the ongoing advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile